DHODH and cancer: Targeting pyrimidine metabolism, specifically by inhibiting dihydroorotate dehydrogenase (DHODH), an enzyme supporting de novo thymidylate and CTP biosynthesis, has shown promise in restraining EBV-transformed B cell proliferation and lytic replication, suggesting therapeutic potential in EBV-associated cancers.